Published in Mech Dev on February 01, 1999
Endocardial cushion and myocardial defects after cardiac myocyte-specific conditional deletion of the bone morphogenetic protein receptor ALK3. Proc Natl Acad Sci U S A (2002) 2.99
An essential role of Bmp4 in the atrioventricular septation of the mouse heart. Genes Dev (2003) 2.95
BMP10 is essential for maintaining cardiac growth during murine cardiogenesis. Development (2004) 2.50
Bone morphogenetic protein-9 is a circulating vascular quiescence factor. Circ Res (2008) 2.43
BMP receptor IA is required in mammalian neural crest cells for development of the cardiac outflow tract and ventricular myocardium. Development (2004) 1.93
Tbx2 and Tbx3 regulate the dynamics of cell proliferation during heart remodeling. PLoS One (2007) 1.26
An in vivo reporter of BMP signaling in organogenesis reveals targets in the developing kidney. BMC Dev Biol (2008) 1.12
Overexpression of bone morphogenetic protein 10 in myocardium disrupts cardiac postnatal hypertrophic growth. J Biol Chem (2006) 1.12
Myocardin regulates BMP10 expression and is required for heart development. J Clin Invest (2012) 1.10
Context-dependent signaling defines roles of BMP9 and BMP10 in embryonic and postnatal development. Proc Natl Acad Sci U S A (2013) 1.07
Analysis of ventricular hypertrabeculation and noncompaction using genetically engineered mouse models. Pediatr Cardiol (2009) 1.04
Molecular genetics and pathogenesis of cardiomyopathy. J Hum Genet (2015) 1.02
Inactivation of the Sema5a gene results in embryonic lethality and defective remodeling of the cranial vascular system. Mol Cell Biol (2005) 1.01
Furin is the major processing enzyme of the cardiac-specific growth factor bone morphogenetic protein 10. J Biol Chem (2011) 0.99
BMP signaling in congenital heart disease: new developments and future directions. Birth Defects Res A Clin Mol Teratol (2011) 0.99
Embryonic cardiac chamber maturation: Trabeculation, conduction, and cardiomyocyte proliferation. Am J Med Genet C Semin Med Genet (2013) 0.96
Mutation and analysis of Dan, the founding member of the Dan family of transforming growth factor beta antagonists. Mol Cell Biol (2001) 0.95
Circulating Bmp10 acts through endothelial Alk1 to mediate flow-dependent arterial quiescence. Development (2013) 0.94
Tbx20 transcription factor is a downstream mediator for bone morphogenetic protein-10 in regulating cardiac ventricular wall development and function. J Biol Chem (2011) 0.86
Emerging roles of BMP9 and BMP10 in hereditary hemorrhagic telangiectasia. Front Genet (2015) 0.81
Highly restricted BMP10 expression in the trabeculating myocardium of the chick embryo. Dev Genes Evol (2004) 0.79
The Prodomain-bound Form of Bone Morphogenetic Protein 10 Is Biologically Active on Endothelial Cells. J Biol Chem (2015) 0.78
Cardiac cell lineages that form the heart. Cold Spring Harb Perspect Med (2014) 0.78
A cross-species analysis of a mouse model of breast cancer-specific osteolysis and human bone metastases using gene expression profiling. BMC Cancer (2011) 0.77
The cell-specific upregulation of bone morphogenetic protein-10 (BMP-10) in a model of rat cortical brain injury. J Mol Histol (2012) 0.76
The promise of recombinant BMP ligands and other approaches targeting BMPR-II in the treatment of pulmonary arterial hypertension. Glob Cardiol Sci Pract (2015) 0.75
Water temperature induces jaw deformity and bone morphogenetic proteins (BMPs) gene expression in golden pompano Trachinotus ovatus larvae. Springerplus (2016) 0.75
BMP-SMAD signalling output is highly regionalized in cardiovascular and lymphatic endothelial networks. BMC Dev Biol (2016) 0.75
ALK1 signaling in development and disease: new paradigms. Cell Mol Life Sci (2017) 0.75
Combined Effects of Bone Morphogenetic Protein 10 and Crossveinless-2 on Cardiomyocyte Differentiation in Mouse Adipocyte-Derived Stem Cells. J Cell Physiol (2017) 0.75
Novel regulators of bone formation: molecular clones and activities. Science (1988) 10.74
Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol (1994) 5.93
Analysis of the tendon cell fate using Scleraxis, a specific marker for tendons and ligaments. Development (2001) 3.79
Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci U S A (1990) 3.52
Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop Relat Res (1998) 2.73
Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5, 6, and 7, members of the TGF-beta gene family. J Clin Invest (1997) 2.42
A truncated bone morphogenetic protein receptor affects dorsal-ventral patterning in the early Xenopus embryo. Proc Natl Acad Sci U S A (1994) 2.40
Bone morphogenetic protein-3 is a negative regulator of bone density. Nat Genet (2001) 2.34
The type I BMP receptor BMPRIB is required for chondrogenesis in the mouse limb. Development (2000) 2.30
Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci U S A (1990) 2.22
Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. J Cell Biol (1998) 2.17
Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol (1991) 2.16
Purification and characterization of other distinct bone-inducing factors. Proc Natl Acad Sci U S A (1988) 2.13
Studies with a Xenopus BMP receptor suggest that ventral mesoderm-inducing signals override dorsal signals in vivo. Cell (1994) 2.12
Isolation of the human gene for bone gla protein utilizing mouse and rat cDNA clones. EMBO J (1986) 2.10
The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem Biophys Res Commun (1990) 1.88
The localized expression of extracellular matrix components in healing tendon insertion sites: an in situ hybridization study. J Orthop Res (2002) 1.85
The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. J Bone Joint Surg Am (1992) 1.79
Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology (1992) 1.75
Induction and maintenance of the neuronal cholinergic phenotype in the central nervous system by BMP-9. Science (2000) 1.68
A novel BMP expressed in developing mouse limb, spinal cord, and tail bud is a potent mesoderm inducer in Xenopus embryos. Dev Biol (1999) 1.64
Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation. J Cell Biochem (1999) 1.54
Bone morphogenetic protein-9. An autocrine/paracrine cytokine in the liver. J Biol Chem (2000) 1.48
Bone morphogenetic proteins inhibit adipocyte differentiation by bone marrow stromal cells. J Cell Biochem (1995) 1.45
Pulmonary vasculitis--an uncommon complication of ulcerative colitis. Report of a case. N Engl J Med (1968) 1.44
Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6. Biochem Biophys Res Commun (1996) 1.42
Bone morphogenetic protein-9 binds to liver cells and stimulates proliferation. Endocrinology (1995) 1.38
Differential regulation of the two principal Runx2/Cbfa1 n-terminal isoforms in response to bone morphogenetic protein-2 during development of the osteoblast phenotype. Endocrinology (2001) 1.34
Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo. Growth Factors (1996) 1.32
The BMP proteins in bone formation and repair. Trends Genet (1992) 1.31
Bone morphogenetic protein-2 inhibits terminal differentiation of myogenic cells by suppressing the transcriptional activity of MyoD and myogenin. Exp Cell Res (1997) 1.29
Consequences of reperfusion after coronary occlusion. Effects on hemodynamic and regional myocardial metabolic function. Am J Cardiol (1974) 1.28
Regulation of skeletal progenitor differentiation by the BMP and retinoid signaling pathways. J Cell Biol (2000) 1.18
Cloning and expression of the Wnt antagonists Sfrp-2 and Frzb during chick development. Dev Biol (2000) 1.14
Gdf11 is a negative regulator of chondrogenesis and myogenesis in the developing chick limb. Dev Biol (2001) 1.14
Responsiveness of clonal limb bud cell lines to bone morphogenetic protein 2 reveals a sequential relationship between cartilage and bone cell phenotypes. J Bone Miner Res (1994) 1.11
Osteochondritis of the first metatarsal sesamoid: report of three cases. Clin Orthop Relat Res (1972) 1.07
A kinase domain-truncated type I receptor blocks bone morphogenetic protein-2-induced signal transduction in C2C12 myoblasts. J Biol Chem (1997) 1.06
Growth factors influencing bone development. J Cell Sci Suppl (1990) 1.03
Immunohistochemical detection of bone morphogenetic proteins in bone and soft-tissue sarcomas. Cancer (1994) 1.00
Different effects of bone morphogenetic proteins 2, 4, 12, and 13 on the expression of cartilage and bone markers in the MC615 chondrocyte cell line. Exp Cell Res (1999) 0.97
A mammalian serine/threonine kinase receptor specifically binds BMP-2 and BMP-4. Biochem Biophys Res Commun (1994) 0.94
Bone morphogenetic proteins-2 and -4 are involved in the retinoic acid-induced differentiation of embryonal carcinoma cells. Mol Biol Cell (1992) 0.94
Glomerular hemodynamic alterations during acute hyperinsulinemia in normal and diabetic rats. Kidney Int (1992) 0.94
The effects of aging on the bone inductive activity of recombinant human bone morphogenetic protein-2. Endocrinology (1996) 0.93
Independent changes in type I and type II receptors for transforming growth factor beta induced by bone morphogenetic protein 2 parallel expression of the osteoblast phenotype. Mol Cell Biol (1995) 0.93
Glucose and insulin regulate insulin sensitivity in primary cultured adipocytes without affecting insulin receptor kinase activity. Endocrinology (1991) 0.89
Dissection of the growth versus metabolic effects of insulin and insulin-like growth factor-I in transfected cells expressing kinase-defective human insulin receptors. J Biol Chem (1990) 0.87
Bone morphogenetic protein-12 and -13 inhibit terminal differentiation of myoblasts, but do not induce their differentiation into osteoblasts. Biochem Biophys Res Commun (1996) 0.84
Expression of bone morphogenetic proteins in human osteosarcoma. Immunohistochemical detection with monoclonal antibody. Cancer (1994) 0.83
Androgen-binding proteins in human benign prostatic hypertrophy. J Clin Endocrinol Metab (1975) 0.82
Signaling pathways in skeletal formation: a role for BMP receptors. Ann N Y Acad Sci (1996) 0.82
Recombinant human bone morphogenetic protein-2 induces a hematopoietic microenvironment in the rat that supports the growth of stem cells. Exp Hematol (1996) 0.81
Characterization of bone morphogenetic protein 4 receptor in fibrodysplasia ossificans progressiva. Clin Orthop Relat Res (1998) 0.81
Effects of GDF7/BMP12 on proliferation and alkaline phosphatase expression in rat osteoblastic osteosarcoma ROS 17/2.8 cells. J Cell Biochem (1999) 0.81
Nitrogen, phosphorus, and potassium uptake by wheat and their distribution in soil following successive, annual compost applications. J Environ Qual (2004) 0.80
Identification of ovarian granulosa cells as a novel site of expression for bone morphogenetic protein-3 (BMP-3/osteogenin) and regulation of BMP-3 messenger ribonucleic acids by chorionic gonadotropin in cultured human granulosa-luteal cells. J Clin Endocrinol Metab (1996) 0.80
Role of glucose in corneal metabolism. Am J Physiol (1985) 0.78
Cellular characteristics of the rejection response to canine lung allotransplants. J Thorac Cardiovasc Surg (1973) 0.78
Changes in bone morphogenetic protein sensitivity relative to differentiation in fetal rat bone cell cultures. Ann N Y Acad Sci (1996) 0.78
Development of immortalized cells derived from 13DPC mouse limb buds as a system to study the effects of recombinant human bone morphogenetic protein-2 (rhBMP-2) on limb bud cell differentiation. Prog Clin Biol Res (1993) 0.78
Unilateral polycystic kidney disease. J Urol (1972) 0.78
Opposing effects by glucocorticoid and bone morphogenetic protein-2 in fetal rat bone cell cultures. J Cell Biochem (1997) 0.77
Allele-specific RNA interference in FOP silencing the FOP gene. Gene Ther (2011) 0.76
Effects of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on embryonic chick bone in organ culture. J Exp Zool (1982) 0.75
Electrical potentials in medullary bone. Clin Orthop Relat Res (1983) 0.75
Effects of parathyroid hormone and calcitonin on embryonic chick bone in organ culture. Gen Comp Endocrinol (1981) 0.75
Release of calcium from bone in vitro by homogenates of embryonic chick parathyroid glands. J Exp Zool (1983) 0.75
Direct current induced mosaic bone architecture. Clin Orthop Relat Res (1974) 0.75
Cadmium-induced experimental Fanconi syndrome. Curr Probl Clin Biochem (1975) 0.75
Stimulation of calcium release from cultured embryonic chick bones by parathyroid glands of the freshwater turtle. Gen Comp Endocrinol (1980) 0.75